Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Y. Lobet"'
Introduction: For persons with hemophilia, optimization of joint outcomes is an important unmet need. The aim of this initiative was to determine use of ultrasound in evaluating arthropathy in persons with hemophilia, and to move toward consensus amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::50c763c4116a86c8e0c4da89aee686a3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102166
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102166
Publikováno v:
Immunology Letters. 39:249-258
The wide distribution of Borrelia burgdorferi, the spirochete causing Lyme borreliosis, represents a human health hazard in many areas of the world. Vaccination has been proposed as an effective prevention strategy. Vaccination experiments were condu
Autor:
Per A. Bullough, C. Feron, Jeremy P. Derrick, Y. Lobet, Mark Achtman, Stephen M. Prince, Barica Kusecek, D. Janssens
Publikováno v:
Acta Crystallographica Section D Biological Crystallography. 57:1164-1166
OpcA is an integral outer membrane from the Gram-negative pathogen Neisseria meningitidis that plays a role in adhesion of meningococci to host cells. The protein was overexpressed in Escherichia coli in an insoluble form and a procedure developed fo
Publikováno v:
Journal of Biological Chemistry. 265:4552-4559
The S1 subunit (Mr 28,000) of pertussis toxin expresses thiol-dependent enzymatic ADP-ribosyltransferase and NAD-glycohydrolase activities. Site-directed mutagenesis experiments were performed on the codon for Cys-41 of this subunit to investigate th
Autor:
Y. Lobet
Publikováno v:
Médecine et Maladies Infectieuses. 28:390-392
Summary A vaccine against Lyme disease has been successfully tested in US endemie areas. It is based on the use of OspA, an outer surface protein of B. burgdorferi , to elicit antibodies able to block the transmission of the bacteria from the tick to
In Europe, Borrelia garinii OspA serotype 4 has been isolated from the cerebrospinal fluid of patients but, up to now, has never been identified among culture isolates from Ixodes ricinus ticks. This information raises the question of whether OspA se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b34c0de98fd05ca2afd21f1ca8b9f6
https://europepmc.org/articles/PMC87897/
https://europepmc.org/articles/PMC87897/
Publikováno v:
Journal of biotechnology. 76(2-3)
Autor:
Peter Hauser, C. Capiau, Y. Lobet, D Dearwester, J C Frantz, P. Voet, William T. Golde, Marc C. Dolan, Joseph Piesman, P. Desmons, M Kramer
The response to recombinant vaccines for Lyme disease was studied to determine serum antibody levels effective in protecting against tick-transmitted infection. Data presented here demonstrate a significant correlation between antibody to an epitope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27df0b8766c8bafeb741d9283e3f8a07
https://europepmc.org/articles/PMC175064/
https://europepmc.org/articles/PMC175064/
Autor:
F. S. Kantor, Richard A. Flavell, Andrew Spielman, Stephen W. Barthold, Y. Lobet, Erol Fikrig, Sam R. Telford
Publikováno v:
The Journal of infectious diseases. 171(5)
Although immunization with recombinant outer surface protein A (OspA) appears to protect mice against infection by the agent of Lyme disease, all reported experiments have involved formulations that would not be suitable for use in humans or have not
Autor:
Alex Bollen, A Ben Messaoud, I Demaerschalck, P Hoet, M De Kesel, Edmond Godfroid, Geoffroy Bigaignon, Bernard Hoyois, Y Lobet
Oligonucleotide primers based on Borrelia burgdorferi sensu lato ospA gene sequences have been designed for use in the PCR to type all (SL primers) or each (GI to GIII primers) of the B. burgdorferi sensu lato genospecies involved in Lyme disease. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d06a44ea639fb649a18a31d2d68fc764
https://europepmc.org/articles/PMC227997/
https://europepmc.org/articles/PMC227997/